Browse > Article
http://dx.doi.org/10.4014/jmb.1812.12046

Soybean Fermented with Bacillus amyloliquefaciens (Cheonggukjang) Ameliorates Atopic Dermatitis-Like Skin Lesion in Mice by Suppressing Infiltration of Mast Cells and Production of IL-31 Cytokine  

Cho, Byoung Ok (Department of Health Management, Jeonju University)
Shin, Jae Young (Department of Health Management, Jeonju University)
Kim, Ji-su (Department of Health Management, Jeonju University)
Che, Denis Nchang (Department of Health Management, Jeonju University)
Kang, Hyun Ju (Research Institute, Ato Q&A Co. Ltd)
Jeong, Do-Youn (Microbial Institute for Fermentation Industry (MIFI))
Jang, Seon Il (Department of Health Management, Jeonju University)
Publication Information
Journal of Microbiology and Biotechnology / v.29, no.5, 2019 , pp. 827-837 More about this Journal
Abstract
The present study was conducted with the aim to investigate the ameliorative effects of a new soybean product (cheonggukjang) fermented with Bacillus amyloliquefaciens SCGB1 (SFBA) in atopic dermatitis (AD) mouse model. Visual evaluation of AD induction in the mice indicated the remarkable control of SFBA in reducing the pathological severity of AD-like skin lesions reported as the SCORAD score of AD clinical symptoms. The results revealed that SFBA reduced dorsal skin and epidermal thickness to a similar extent with prednisolone. Further analysis revealed the dominance of SFBA in restraining mast cell infiltration in the dermis; immunoglobulin-E expression in serum; and TH2 IL-4 cytokine and itch-related IL-31 cytokine in the mice skin and serum. SFBA also suppressed scratching behaviours in mice induced by compound 48/80. Further histological findings also revealed the alleviation of collagen fiber deposition in dermal skin of the AD mice model. These actions of SFBA were examined to be mediated by its suppression of the phosphorylation activation of key signalling molecules such as $NF-{\kappa}B$ and MAPK responsible for the induction of cytokine production. Thus, SFBA can be considered as a promising functional food for managing clinical, histological and immunological spectra associated with AD.
Keywords
Cheonggukjang; Bacillus amyloliquefaciens SCGB1; atopic dermatitis; scratching behaviour; IL-31; collagen;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hussain Z, Katas H, Mohd Amin MCI, Kumolosasi E. 2014. Efficient immuno-modulation of T(H1)/T(H2) biomarkers in 2,4-dinitrofluorobenzene-induced atopic dermatitis: nanocarriermediated transcutaneous co-delivery of anti-inflammatory and antioxidant drugs. PLoS One 9: e113143.   DOI
2 Tanaka A, Muto S, Jung K, Itai A, Matsuda H. 2007. Topical application with a new NF-${\kappa}B$ inhibitor improves atopic dermatitis in NC/NgaTnd mice. J. Invest. Dermatol. 127: 855-863.   DOI
3 Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K, Iversen L. 2005. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br. J. Dermatol. 152: 37-42.   DOI
4 Su CL, Wu CJ, C h en FN, Wang BJ, Sheu SR, Won SJ. 2007. Supernatant of bacterial fermented soybean induces apoptosis of human hepatocellular carcinoma Hep 3B cells via activation of caspase 8 and mitoch ondria. Food Chem. Toxicol. 45: 303-314.   DOI
5 Ferretti E, Corcione A, Pistoia V. 2017. The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment. J. Leukoc. Biol. 102: 711-717.   DOI
6 Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, DeBenedetto A, et al. 2009. Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol. 124: R7-R12.   DOI
7 Kim BE, Leung DY, Boguniewicz M, Howell MD. 2008. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin. Immunol. 126: 332-337.   DOI
8 Liu FT, Goodarzi H, Chen HY. 2011. IgE, mast cells, and eosinophils in atopic dermatitis. Clin. Rev. Allergy Immunol. 41: 298-310.   DOI
9 Nobbe S, Dziunycz P, Muhleisen B, Bilsborough J, Dillon SR, French LE, et al. 2012. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. Acta Derm. Venereol. 92: 24-28.   DOI
10 Takaoka A, Arai I, Sugimoto M, Yamaguchi A, Tanaka M, Nakaike S. 2005. Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur. J. Pharmacol. 516:180-181.   DOI
11 Toda M, L eung D Y, M olet S, Boguniewicz M, T ah a R, Christodoulopoulos P, et al. 2003. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J. Allergy Clin. Immunol. 111: 875-881.   DOI
12 Bae MJ, Shin HS, See HJ, Chai O H, Shon DH. 2014. Cheonggukjang ethanol extracts inhibit a murine allergic asthma via suppression of mast cell-dependent anaphylactic reactions. J. Med. Food 17: 142-149.   DOI
13 Nakajima N, Nozaki N, Ishihara K, Ishikawa A, Tsuji H. 2005. Analysis of isoflavone content in tempeh, a fermented soybean, and preparation of a new isoflavone-enriched tempeh. J. Biosci. Bioeng. 100: 685-687.   DOI
14 Soh J, Kwon DY, Cha YS. 2011. Hepatic gene expression profiles are altered by dietary unsalted korean fermented soybean (chongkukjang) consumption in mice with dietinduced obesity. J. Nutr. Metab. 2011: 260214.
15 Kwon DY, Daily JW, 3rd, Kim HJ, Park S. 2010. Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr. Res. 30: 1-13.   DOI
16 Choi YH, Lim H, Heo MY, Kwon DY, Kim HP. 2008. Antiinflammatory activity of the ethanol extract of Chungkukjang, Korean fermented bean: 5-lipoxygenase inhibition. J. Med. Food 11: 539-543.   DOI
17 Dajee M, Muchamuel T, Schryver B, Oo A, Alleman-Sposeto J, De Vry CG, et al. 2006. Blockade of experimental atopic dermatitis via topical NF-${\kappa}B$ Decoy Oligonucleotide. J. Invest. Dermatol. 126: 1792-1803.   DOI
18 Mihara K, Kuratani K, Matsui T, Nakamura M, Yokota K. 2004. Vital role of the itch-scratch response in development of spontaneous dermatitis in NC/Nga mice. Br. J. Dermatol. 151: 335-345.   DOI
19 Cho BO, Che DN, Yin HH, Shin JY, Jang SI. 2017. Diospyros lotus leaf and grapefruit stem extract synergistically ameliorate atopic dermatitis-like skin lesion in mice by suppressing infiltration of mast cells in skin lesions. Biomed. Pharmacother. 89: 819-826.   DOI
20 Shin JU, Kim SH, Kim H, Noh JY, Jin S, Park CO, et al. 2016. TSLP is a potential initiator of collagen synthesis and an ctivator of CXCR4/SDF-1 axis in keloid Pathogenesis. J. Invest. Dermatol. 136: 507-515.   DOI
21 Kishimoto T, Hirano T. 1988. Molecular regulation of B lymphocyte response. Annu. Rev. Immunol. 6: 485-512.   DOI
22 Kang MJ, Eum JY, Park SH, Kang MH, Park KH, Choi SE, et al. 2010. Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice. Int. J. Pharm. 402: 198-204.   DOI
23 Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, et al. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9: 461-466.   DOI
24 Philips N, Samuel M. 2017. Inhibition of Interleukin-4 signalling in the treatment of atopic dermatitis and allergic asthma. Glob. J. Allergy 3: 019-021.   DOI
25 Wong LS, Wu T, Lee C-H. 2017. Inflammatory and noninflammatory itch: implications in pathophysiologydirected treatments. Int. J. Mol. Sci. 18: 1485.   DOI
26 Jin H, He R, Oyoshi M, Geha R. 2009. Animal models of atopic dermatitis. J. Invest. Dermatol. 129: 31-40.   DOI
27 Ribeiro-Filho J, Leite FC, Costa HF, Calheiros AS, Torres RC, de Azevedo CT, et al. 2014. Curine inhibits mast cell-dependent responses in mice. J. Ethnopharmacol. 155: 1118-1124.   DOI
28 Brandt EB, Sivaprasad U. 2011. Th2 cytokines and a topic dermatitis. J. Clin. Cell. Immunol. 2: pii:110.
29 Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI. 2009. Global variations in prevalence of eczema symptoms in children from ISAAC phase three. J. Allergy Clin. Immunol. 124: 1251-1258.   DOI
30 Novak N. 2012. An update on the role of human dendritic cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. 129: 879-886.   DOI